Zobrazeno 1 - 10
of 29
pro vyhledávání: '"N G, Gogolashvili"'
Publikováno v:
Сибирский научный медицинский журнал, Vol 43, Iss 4, Pp 123-131 (2023)
The available data convincingly show the presence of multiple pathophysiological links that explain the high probability of developing metabolic syndrome (MetS) in patients with affective disorders, and MetS itself has been proposed as a premorbid co
Externí odkaz:
https://doaj.org/article/c93baa171b5f45f3ab86f308b31fe290
Autor:
N. G. Gogolashvili
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 6 (2023)
High rates of cardiovascular (CV) morbidity and mortality dictates the need to determine approaches to therapy that would reduce complications rate and improve patient’s prognosis. High-intensity statin therapy is an integral part of the treatment
Externí odkaz:
https://doaj.org/article/df1e87886b4e491bb0f46e134bdc7b2f
Autor:
N. G. Gogolashvili, R. A. Yaskevich
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 20, Iss 8 (2022)
Aim. To study the prescription rate of lipid-lowering therapy and achieving the target low-density lipoprotein cholesterol (LDL-C) values in outpatients with coronary artery disease (CAD) living in Krasnoyarsk.Material and methods. The study included
Externí odkaz:
https://doaj.org/article/2c12b80ee451426e86718fffdaf6e08c
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 1, Pp 43-48 (2019)
Aim. To evaluate the volume of antithrombotic therapy (ATT) at the prehospital stage in connection with the risk of thromboembolic complications, and also to study the dynamics of the frequency of administration of oral anticoagulants (ОAC) in patie
Externí odkaz:
https://doaj.org/article/aeb3c0821bd84e57bd7089f24cf1b6e0
Autor:
N. G. Gogolashvili
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 2, Pp 134-149 (2018)
The efficacy and safety of atorvastatin discussed for the decrease of cardiovascular complications development.
Externí odkaz:
https://doaj.org/article/7f0c22b73fc54a2499c83dae53213d7a
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 13, Iss 3, Pp 403-408 (2017)
Arrhythmias are one of the most complex, insufficiently studied, and therefore one of the most urgent problems of modern cardiology. A wide spectrum of clinical manifestations of cardiac rhythm disorders (CRDs), their detection both in various diseas
Externí odkaz:
https://doaj.org/article/bc2c9a7c29d34fa0b5c60c987a765c7d
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 12, Iss 4, Pp 391-395 (2016)
Aim. To study the relationship of arrhythmias, registered by the electrocardiography (ECG) and ECG Holter monitoring, with the changes of the heart and disorders of its function detected by echocardiography in the adult population of the Arctic, livi
Externí odkaz:
https://doaj.org/article/a28e71c518ce45cb8bb52ece540ad0e9
Autor:
N. G. Gogolashvili
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 10, Iss 4, Pp 438-443 (2015)
The possibility of atorvastatin in reducing the risk of periprocedural myocardial infarction and other cardiovascular events in patients with percutaneous coronary intervention is discussed.
Externí odkaz:
https://doaj.org/article/5e6da3dba7174db1ac662511ac49d73b
Autor:
Olga Barbarash, O. Yu. Shabelnikova, S. A. Makarov, A. A. Garganeeva, V. V. Kashtalap, K. V. Protasov, O. Yu. Korennova, V. A. Nevzorova, S. A. Ustyugov, N. G. Gogolashvili, A. A. Efremushkina, S. L. Zharskiy
Publikováno v:
Complex Issues of Cardiovascular Diseases. 10:103-108
The results of the international multicenter study EMPEROR-Reduced have been discussed on October 31, 2020, at the online expert meeting. Considering the positive cardiovascular and renal effects of empagliflozin, the experts have supported the use o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eaa10a8cb06b90de7704455dbae7d47d
https://doi.org/10.17802/2306-1278-2021-10-1-103-108
https://doi.org/10.17802/2306-1278-2021-10-1-103-108
Autor:
N. G. Gogolashvili, M. V. Litvinenko, T. N. Pochikaeva, E. S. Vavitova, L. S. Polikarpov, N. Ya. Novgorodtseva
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 10, Iss 5, Pp 57-62 (2011)
Aim. To study the prevalence of ventricular arrhythmias (VA) in the patients who suffered myocardial infarction (MI) within the last year; to evaluate the effects of the treatment with omega-3 polyunsaturated fatty acids (PUFA) for 6 months. Material
Externí odkaz:
https://doaj.org/article/50a0271608d74e1c92a463531d6e0841